What motivates primary care providers to prescribe mifepristone medication abortion? Results of a qualitative investigation in Canada
Our results highlight that, after five years, barriers still exist to providing mifepristone medication abortion in Canadian primary care. We illustrate the importance of addressing ongoing perceptions of logistical barriers to care, concerns about advertising abortion services to the community, and the need for robust mentorship and consultation pathways.
Authors
- Aleyah Williams (ORCID: https://orcid.org/0009-0006-8199-3658)
- Kate Wahl
- Madeleine Ennis (ORCID: https://orcid.org/0000-0002-1263-2676)
- Sarah A. Munro
Institutions
- University of British Columbia (CA)
- University of Washington (US)
- Department of Health (TW)
- Seattle University (US)
Publication Details
- Journal
- BMC Primary Care
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1186/s12875-025-03043-1
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Michael Smith Health Research BC
- Health Canada
- Canadian Institutes of Health Research